Sanofi India informs about board meeting
Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sanofi India has informed that the meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 28th April 2026, to consider and approve the Unaudited Financial Results for the quarter ended 31st March 2026. Further, in reference to intimation dated 24th March 2026 for closure of trading window, the trading window for the purpose of publication of Unaudited Financial Results of the Company for the quarter ended 31st March 2026 shall remain closed from Wednesday, 1st April 2026 till to Thursday, 30th April 2026.
The above information is a part of company’s filings submitted to BSE.
